临床试验方法

Application of biomarkers in oncology clinical trials

Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh

• 抽象的

药物评价

Review of tofacitinib in rheumatoid arthritis

Maria A Lopez-Olivo, Huifang Lu & Jean H Tayar

• 抽象的

评论文章

Angiokinase inhibitors in non-small-cell lung cancer

Wei-Chen Lu, Chia-Chi Lin, & James Chih-Hsin Yang

• 抽象的

看法

Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors

Michael P Chu, Vijaya L Damaraju & Michael B Sawyer

• 抽象的

临床试验结果

Chemotherapeutic treatment of acute myeloid leukemia: incorporating the results of recent clinical trials

Ali J Mahdi, Eamon J Mahdi & Steven Knapper

• 抽象的

临床试验结果

Cancer therapy with Newcastle disease virus: rationale for new immunotherapeutic combinations

Tamar Plitt & Dmitriy Zamarin

• 抽象的

药物评价

Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease

Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov

• 抽象的